Granules arm gets American health regulator's nod for Potassium Chloride Oral Solution

In a BSE filing, Granules said the US Food and Drug Administration (USFDA) has approved the abbreviated new drug application (ANDA) filed by Granules Pharmaceuticals, Inc (GPI), a wholly-owned foreign subsidiary of Granules India Ltd, for Potassium Chloride Oral Solution USP.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/3pAizeI
via IFTTT